Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells

Journal of Cellular Biochemistry

Volumn 95, Issue 6, 2005, Pages 1276-1283

  Shouhed, Daniel ^a   Kha, Hoa Ton ^a   Richardson, Jennifer A ^a   Amantea, Christopher M ^a   Hahn, Theodore J ^a,b   Parhami, Farhad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Marrow stromal cells; Osteogenic differentiation; Oxidative stress; Oxysterols

Indexed keywords

20 HYDROXYCHOLESTEROL; 22 HYDROXYCHOLESTEROL; ALKALINE PHOSPHATASE; CHOLESTEROL; CHOLESTEROL DERIVATIVE; LOW DENSITY LIPOPROTEIN; OSTEOCALCIN; OXYSTEROL; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

AGING; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DEFENSE MECHANISM; ENZYME ACTIVITY; MENOPAUSE; MOUSE; NONHUMAN; OSTEOPOROSIS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

ANIMALS; BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CHOLESTEROL, LDL; ENZYME INHIBITORS; HYDROXYCHOLESTEROLS; MICE; OSTEOBLASTS; OSTEOGENESIS; OXIDATIVE STRESS; STROMAL CELLS; XANTHINE OXIDASE;

EID: 26444564340     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20497     Document Type: Article

References (34)

1. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. 2001. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275-279.
2. Bjorkhem I, Diczfalusy U. 2002. Oxysterols: Friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22:734-742.
3. Chan GK, Duque G. 2002. Age-related bone loss: Old bone, new facts. Gerontology 48:62-71.
4. Chang SP, Yang WS, Lee SK, Min WK, Park JS, Kim SB. 2002. Effects of hormonal replacement therapy on oxidative stress and total antioxidant capacity in postmenopausal hemodialysis patients. Ren Fail 24:49-57.
5. Chen XD, Shi S, Xu T, Robey PG, Young MF. 2002. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17:331-340.
6. Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshi K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC. 2002. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17:1430-1440.
7. Cummings SR, Melton LJ III. 2002. Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767.
8. Edwards PA, Ericsson J. 1999. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157-185.
9. Ettinger MP. 2003. Aging bone and osteoporosis. Arch Intern Med 163:2237-2246.
10. Finkel T. 2003. Oxidant signals and oxidative stress. Curr Opin Cell Bio 15:247-254.
11. Garrett R, Boyce BF, Oreffo ROC, Bonewald L, Poser J, Mundy GR. 1990. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632-639.
12. Havel RJ, Eder HA, Bragdon JH. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins of human serum. J Clin Invest 43:1343-1345.
13. Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL. 1998. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 13:205-217.
14. Ichioka N, Inaba M, Kushida T, Esumi T, Takahara K, Inaba K, Ogawa R, Iida H, Ikehara S. 2002. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 20:542-551.
15. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F. 2004. Oxysterols regulate differentiation of mesenchymal stem cells: Pro-bone and antifat. J Bone Miner Res 19:830-840.
16. Lyons MA, Samman S, Gatto L, Brown AJ. 1999. Rapid hepatic metabolism of 7-ketocholesterol in vivo: Implications for dietary oxysterols. J Lipid Res 40:1846-1857.
17. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A. 2003. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. Clin Endocrinol & Metab 88:1523-1527.
18. Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S. 1999. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129-135.
19. Mody N, Parhami F, Sarafian TA, Demer LL. 2001. Differential effects of oxidative stress on osteoblastic differentiation of vascular and bone cells. Free Radic Res Med 31:509-519.
20. Mullender MG, van der Meer DD, Huiskes R, Lips P. 1996. Osteocyte density changes in aging and osteoporosis. Bone 18:109-113.
21. Mundy GR. 2002. Directions of drug discovery in osteoporosis. Annu Rev Med 53:337-354.
22. Nuttall ME, Gimble JM. 2000. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184.
23. Parhami F. 2003. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 68:373-378.
24. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL. 1999. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067-2078.
25. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16:182-188.
26. Quarto R, Thomas D, Liang CT. 1995. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56:123-129.
27. Rickard DJ, Sullivan TA, Shenker BJ, LeBoy PS, Kazhdan I. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228.
28. Rodan GA, Martin TJ. 2002. Therapeutic approaches to bone diseases. Science 289:1508-1514.
29. Russell DW. 2000. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 1529:126-135.
30. Schaafsma A, de Vries PJ, Saris WH. 2001. Delay of natural bone loss by higher intake of specific minerals and vitamins. Crit Rev Food Sci Nutr 41:225-249.
31. Schroepfer GJ. 2000. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 80:361-554.
32. Simon AM, Manigrasso MB, O'Connor JP. 2002. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17:963-976.
33. Sohal RS, Mockett RJ, Orr WC. 2002. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radical Biol Med 33:575-586.
34. Zhang X, Schwartz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.